From 8580ca85060260764f54c54c874c88ebfbed0181 Mon Sep 17 00:00:00 2001
From: Fran <66632994+FranSoriano@users.noreply.github.com>
Date: Mon, 28 Oct 2024 17:14:41 +0100
Subject: [PATCH] Feat content update 2024 oct (#55)

---
 content/en/publications/2024.md | 15 +++++++++++++++
 1 file changed, 15 insertions(+)

diff --git a/content/en/publications/2024.md b/content/en/publications/2024.md
index 7b1641b..48a2b64 100644
--- a/content/en/publications/2024.md
+++ b/content/en/publications/2024.md
@@ -15,6 +15,21 @@ hero:
 autonumbering: true
 ---
 
+#### TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells
+Priego N, de Pablos-Aragoneses A, Perea-García M, Pieri V, Hernandez-Oliver C, Alvaro-Espinosa L, Rojas A, Sanchez O, Steindl A, Caleiras E, Garcia F, **Garcia-Martin S**, **Grana-Castro O**, Garcia-Mulero S, Serrano D, Velasco-Beltran P, Jimenez-Lasheras B, Egia-Mendikute L, Rupp L, Stammberger A, Meinhardt M, Chaachou-Charradi A, Martínez-Saez E, Bertero L, Cassoni P, Mangherini L, Pellerino A, Ruda R, Soffietti R, **Al-Shahrour F**, Saftig P, Sanz-Pamplona R, Schmitz M, Crocker SJ, Calvo A, Palazon A, Group R, Valiente M.  
+**Cancer Discov**. 2024 Oct 2. doi: 10.1158/2159-8290.CD-24-0134. Epub ahead of print.  
+PMID: [39354883](https://pubmed.ncbi.nlm.nih.gov/39354883/)
+
+#### Renal fibroblasts are involved in fibrogenic changes in kidney fibrosis associated with dysfunctional telomeres
+Saraswati S, Martínez P, Serrano R, Mejías D, **Graña-Castro O**, **Álvarez Díaz R**, Blasco MA.  
+**Exp Mol Med**. 2024 Oct 1. doi: 10.1038/s12276-024-01318-8. Epub ahead of print.  
+PMID: [39349834](https://pubmed.ncbi.nlm.nih.gov/39349834/)
+
+#### MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
+Monteagudo M, Calsina B, Salazar-Hidalgo ME, Martínez-Montes ÁM, **Piñeiro-Yáñez E**, Caleiras E, Martín MC, Rodríguez-Perales S, Letón R, Gil E, Buffet A, Burnichon N, Fernández-Sanromán Á, Díaz-Talavera A, Mellid S, Arroba E, Reglero C, Martínez-Puente N, Roncador G, Del Olmo MI, Corrales PJP, Oliveira CL, Álvarez-Escolá C, Gutiérrez MC, López-Fernández A, García NP, Regojo RM, Díaz LR, Laorden NR, Guadarrama OS, Bechmann N, Beuschlein F, Canu L, Eisenhofer G, Fassnacht M, Nölting S, Quinkler M, Rapizzi E, Remde H, Timmers HJ, Favier J, Gimenez-Roqueplo AP, Rodriguez-Antona C, Currás-Freixes M, **Al-Shahrour F**, Cascón A, Leandro-García LJ, Montero-Conde C, Robledo M.  
+**Best Pract Res Clin Endocrinol Metab**. 2024 Aug 29:101931. doi: 10.1016/j.beem.2024.101931. Epub ahead of print.  
+PMID: [39218714](https://pubmed.ncbi.nlm.nih.gov/39218714/)
+
 #### Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors
 Fernández-García F, Fernández-Rodríguez A, **Fustero-Torre C**, **Piñeiro-Yáñez E**, Wang H, Lechuga CG, Callejas S, Álvarez R, López-García A, Esteban-Burgos L, Salmón M, San Román M, Guerra C, Ambrogio C, Drosten M, Santamaría D, **Al-Shahrour F**, Dopazo A, Barbacid M, Musteanu M.  
 **Proc Natl Acad Sci U S A**. 2024 Sep 3;121(36):e2402913121. doi: 10.1073/pnas.2402913121. Epub 2024 Aug 26.